See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645469_2018_Monopar_Therapeutics.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001645469, Monopar Therapeutics
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,131,236 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 800,031 |
| 4 | LiabilitiesCurrent | 311,867 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,166,186 |
| 9 | ResearchAndDevelopmentExpense | 935,319 |
| 10 | remainder_Expenses | 14,501,622 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 48,255 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,931,267 |
| 1 | Liabilities | 311,867 |
| 2 | Expenses | 16,603,127 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 9,619,400 |
| 5 | NetIncome | -16,554,872 |
| 6 | ComprehensiveNetIncome | -16,554,872 |
| 7 | BaseVar | 13,447,258 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.862 |
| 9 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
